Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: 10.1111/bjh.13801
- Ereignis
-
Veröffentlichung
- (wo)
-
Aachen
- (wer)
-
Universitätsbibliothek der RWTH Aachen
- (wann)
-
2015
- Urheber
-
Brümmendorf, Tim Henrik
Cortes, Jorge E.
Khoury, Hanna J.
Kantarjian, Hagop M.
Kim, Dong-Wook
Schafhausen, Philippe
Conlan, Maureen G.
Shapiro, Mark
Turnbull, Kathleen
Leip, Eric
Gambacorti-Passerini, Carlo
Lipton, Jeff H.
- DOI
-
10.18154/RWTH-CONV-211191
- URN
-
urn:nbn:de:101:1-2018101106081011988114
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:44 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Brümmendorf, Tim Henrik
- Cortes, Jorge E.
- Khoury, Hanna J.
- Kantarjian, Hagop M.
- Kim, Dong-Wook
- Schafhausen, Philippe
- Conlan, Maureen G.
- Shapiro, Mark
- Turnbull, Kathleen
- Leip, Eric
- Gambacorti-Passerini, Carlo
- Lipton, Jeff H.
- Universitätsbibliothek der RWTH Aachen
Entstanden
- 2015
Ähnliche Objekte (12)
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial
Neutrophil biology in chronic lymphocytic leukaemia and infections
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Antigen-independent signalling of the antigen receptor in chronic lymphocytic leukaemia : pathophysiological relevance
Expression of SLC transporters in chronic lymphocytic leukaemia cells and their interaction with cytostatics
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial
Neutrophil biology in chronic lymphocytic leukaemia and infections
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Antigen-independent signalling of the antigen receptor in chronic lymphocytic leukaemia : pathophysiological relevance
Expression of SLC transporters in chronic lymphocytic leukaemia cells and their interaction with cytostatics
Alterations of Gab2 signalling complexes in imatinib and dasatinib treated chronic myeloid leukaemia cells
Specific, targetable interactions with the microenvironment influence imatinib-resistant chronic myeloid leukemia
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia : results from the 24-month follow-up of the BELA trial
Neutrophil biology in chronic lymphocytic leukaemia and infections
Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia : final results from the BFORE trial
Sequence analysis of the NUMB gene in chronic myeloid leukaemia patients
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia
Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
Antigen-independent signalling of the antigen receptor in chronic lymphocytic leukaemia : pathophysiological relevance